Story perspectives

Trump Hints at Tariff Delay to Boost US Pharma

5/2/2025

38 6

Left

Trump Postpones Tariffs

Donald Trump hinted at postponing tariffs for pharmaceutical companies during a recent White House meeting, encouraging them to move operations back to the US. He assured them they would have time to adapt, while highlighting substantial investments from various firms, signaling a strategic shift to ease business worries in a challenging economy.

Center

Ricks Warns Tariffs

Eli Lilly's CEO, David Ricks, voiced alarm over looming U.S. tariffs on pharmaceuticals, warning they could jeopardize national security and disrupt drug supply. He argued that tariffs may be unnecessary, as companies are already bringing manufacturing back home. In response, EU officials cautioned that the U.S. probe into drug imports could severely impact healthcare and inflate prices.

History

Historical Context

Donald Trump's recent hints at postponing pharmaceutical tariffs reflect a long-standing trend in U.S. manufacturing policy. Since the 1960s, U.S. companies have increasingly outsourced production to countries like Mexico under programs like the Maquiladora. The current push to bring manufacturing back home echoes past efforts to strengthen domestic industries, particularly in response to global competition and supply chain vulnerabilities highlighted during the COVID-19 pandemic.

1 of 3

Trump Postpones Tariffs

Donald Trump hinted at postponing tariffs for pharmaceutical companies during a recent White House meeting, encouraging them to move operations back to the US. He assured them they would have time to adapt, while highlighting substantial investments from various firms, signaling a strategic shift to ease business worries in a challenging economy.

1 / 3